Study links Parkinson’s hallucinations to low brain chemical activity

People with Parkinson’s disease who experience visual hallucinations have reduced activity in the brain’s cholinergic system, a network of nerve cells that use the chemical messenger acetylcholine, a brain imaging study found. Impaired cholinergic signaling in certain brain regions early on predicted who would later develop visual hallucinations. The researchers said measuring cholinergic activity…